2Halota W,Jaruga B,Pawlowska M.Serum neopterin and beta2-microglobulin concentration as ″prognostic markers″ of AIDS.Pol Merkuriusz Lek,2002,13:126-128.
3Hogan CM,Hammer SM.Host determinants in HIV infection and disease.Ann Intern Med,2001,134(9Pt1):761-776.
2Johnston MI. HIV vaccine development. Dev Bio1,2002,110: 57-63.
3Marcus U, Dittmar MT, Krausslich HG, et al. HIV: Epidemiology and strategies for therapy and vaccination. Intervirology, 2002,45:260-266.
4Peakman M, Mahalingam M, Pozniak A, et al. Markers of immune cell activation and disease progression. Cell activation in HIV disease. Adv Exp Med Biol, 1995,374:17-26.
5Hogan CM, Hammer SM. Host Determinants in HIV infection and disease. Ann Intern Med,2001,134:761-776.
6Bartlett JG. 1998 medical management of HIV infection. Port City Press, 1998, 63-86.
8REYNKS J,PORTALES P, SEGONDY M,et al. CD4^+ T cell surface CCR5 density as determining factor of virus load in persons infected with human immtmodeficiency virus type 1 [J].J Inf Dis,2000,181(3) :927.
9Murkami T, Yamamoto N. Roles of chemokines and chemokine receptors in HIV-1 infection[J]. Int J Hematol,2000,72 (4):412.
10NICHOLSON J K, BROWNING S W, HENGELR L, et al. CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy[J]. J Acquir Immune Defic Syndr, 2001,27 (2): 105.
